Skip to main content
Log in

The Level of Anti-Polyethylene Glycol (PEG) Immunoglobulin G Antibodies in Human Serum Does Not Correlate with Efficiency of PEGylated Nanoparticle Uptake by Monocytes

  • BIOTECHNOLOGIES
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

The presence of anti-polyethylene glycol (PEG) antibodies can limit the clinical efficacy of PEGylated drugs and cause anaphylactic reactions in patients. Monocytes/macrophages are effector cells involved in IgG-mediated passive systemic anaphylaxis. We studied the influence of human blood serum on the efficiency of uptake of PEGylated nanoparticles by human blood monocytes. It has been shown that magnetic nanoparticles modified with PEG-3000 and solid lipid nanoparticles containing PEG-2000 are avidly internalized by human blood monocytes in vitro, the uptake efficiency depends on the features (composition) of donor blood serum, but does not correlate with the level of the IgG antibody against PEG.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chen BM, Cheng TL, Roffler SR. Polyethylene glycol immunogenicity: theoretical, clinical, and practical aspects of anti-polyethylene glycol antibodies. ACS Nano. 2021;15(9):14 022-14 048. doi: https://doi.org/10.1021/acsnano.1c05922

  2. Sellaturay P, Nasser S, Ewan P. Polyethylene glycol-induced systemic allergic reactions (anaphylaxis). J. Allergy Clin. Immunol. Pract. 2021;9(2):670-675. doi: https://doi.org/10.1016/j.jaip.2020.09.029

    Article  CAS  PubMed  Google Scholar 

  3. Jönsson F, Mancardi DA, Zhao W, Kita Y, Iannascoli B, Khun H, van Rooijen N, Shimizu T, Schwartz LB, Daëron M, Bruhns P. Human FcγRIIA induces anaphylactic and allergic reactions. Blood. 2012;119(11):2533-2544. doi: https://doi.org/10.1182/blood-2011-07-367334

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Escribese MM, Rosace D, Chivato T, Fernández TD, Corbí AL, Barber D. Alternative anaphylactic routes: the potential role of macrophages. Front. Immunol. 2017;8:515. doi: https://doi.org/10.3389/fimmu.2017.00515

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Bigini P, Gobbi M, Bonati M, Clavenna A, Zucchetti M, Garattini S, Pasut G. The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines. Nat. Nanotechnol. 2021;16(11):1169-1171. doi: https://doi.org/10.1038/s41565-021-01001-3

    Article  CAS  PubMed  Google Scholar 

  6. Yang Q, Jacobs TM, McCallen JD, Moore DT, Huckaby JT, Edelstein JN, Lai SK. Analysis of pre-existing IgG and IgM antibodies against polyethylene glycol (PEG) in the general population. Anal. Chem. 2016;88(23):11 804-11 812. doi: https://doi.org/10.1021/acs.analchem.6b03437

  7. Demin AM, Pershina AG, Minin AS, Mekhaev AV, Ivanov VV, Lezhava SP, Zakharova AA, Byzov IV, Uimin MA, Krasnov VP, Ogorodova LM. PMIDA-modified Fe3O4 magnetic nanoparticles: synthesis and application for liver MRI. Langmuir. 2018;34(11):3449-3458. doi: https://doi.org/10.1021/acs.langmuir.7b04023

    Article  CAS  PubMed  Google Scholar 

  8. Lv X, Zhang C, Shuaizhen Q, Yu R, Zheng Y. Design of integrin αvβ3 targeting self-assembled protein nanoparticles with RGD peptide. Biomed. Pharmacother. 2020;128:110236. doi: https://doi.org/10.1016/j.biopha.2020.110236

  9. Reyes-González JM, Armaiz-Peña GN, Mangala LS, Valiyeva F, Ivan C, Pradeep S, Echevarría-Vargas IM, Rivera-Reyes A, Sood AK, Vivas-Mejía PE. Targeting c-MYC in platinum-resistant ovarian cancer. Mol. Cancer Ther. 2015;14(10):2260-2269. doi: https://doi.org/10.1158/1535-7163.MCT-14-0801

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Lubich C, Allacher P, de la Rosa M, Bauer A, Prenninger T, Horling FM, Siekmann J, Oldenburg J, Scheiflinger F, Reipert BM. The mystery of antibodies against polyethylene glycol (PEG) — what do we know? Pharm. Res. 2016;33(9):2239-2249. doi: https://doi.org/10.1007/s11095-016-1961-x

    Article  CAS  PubMed  Google Scholar 

  11. Bournazos S, Gupta A, Ravetch JV. The role of IgG Fc receptors in antibody-dependent enhancement. Nat. Rev. Immunol. 2020;20(10):633-643. doi: https://doi.org/10.1038/s41577-020-00410-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. G. Pershina.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 175, No. 2, pp. 239-243, February, 2023

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nevskaya, K.V., Krivoshchekov, S.V., Zima, A.P. et al. The Level of Anti-Polyethylene Glycol (PEG) Immunoglobulin G Antibodies in Human Serum Does Not Correlate with Efficiency of PEGylated Nanoparticle Uptake by Monocytes. Bull Exp Biol Med 175, 270–274 (2023). https://doi.org/10.1007/s10517-023-05848-5

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-023-05848-5

Keywords

Navigation